Marker Therapeutics, Inc.

Monthly Archives: June 2014

TapImmune Appoints Leading Immunotherapy Researcher to Chair Scientific Advisory Board


TapImmune Inc. (TPIV) is pleased to announce that Dr. Keith Knutson, PhD ( has been appointed to chair the company’s scientific advisory board. Dr. Knutson is Director of the Cancer Vaccines and Immune Therapies Program at the Vaccine & Gene Therapy Institute of Florida, a nonprofit biomedical research institute in Port St.

Read More